Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001326732-25-000015
Filing Date
2025-02-24
Accepted
2025-02-24 08:02:42
Documents
108
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A xncr-20231231.htm   iXBRL 10-K/A 2171090
2 EX-23.1 xncr-20231231xexx231.htm EX-23.1 2440
3 EX-31.1 xncr-20231231xexx311.htm EX-31.1 10091
4 EX-31.2 xncr-20231231xexx312.htm EX-31.2 10340
5 EX-32.1 xncr-20231231xexx321.htm EX-32.1 4739
6 EX-32.2 xncr-20231231xexx322.htm EX-32.2 4955
  Complete submission text file 0001326732-25-000015.txt   11777113

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xncr-20231231.xsd EX-101.SCH 88120
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xncr-20231231_cal.xml EX-101.CAL 108957
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xncr-20231231_def.xml EX-101.DEF 518811
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xncr-20231231_lab.xml EX-101.LAB 859046
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xncr-20231231_pre.xml EX-101.PRE 773072
111 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20231231_htm.xml XML 1809899
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-36182 | Film No.: 25654278
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)